Reimagining drug stores as gateways to wellness
By Rachel Tetreault, general manager for omnichannel health care at Market Performance Group
Opinion
TSE brings an opportunity to empower pharmacy
Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores looks at attendees embracing technology, advancing public policy and uniting around common goals as the industry prepares for the show.
Built for Yesterday, Losing Today: Reinvent From Aisle to Algorithm
By Parag Shah | Co-Founder & Partner, Think Blue Consulting. Data courtesy: NielsenIQ (NIQ).
Weinswig has given Coresight unequaled value
David Pinto looks at Coresight Research and its creative leader Deborah Weinswig.
AI’s impact is on full display at Walmart
AI evolution is on full display at Walmart, which in recent weeks has launched a range of AI tools designed to enhance the shopping experience and make store associates and employees at other facilities more responsive and productive.
NACDS Foundation is worthy of support
Ongoing for the past six months, engagement between NACDS Foundation president Sara Roszak, her team and board members promises to produce a plan that finds innovative ways to further the foundation’s overarching mission.
Five reasons behind the decline of the industry
David Pinto answers the question What has gone wrong with the chain drug store industry in America?
Rite Aid's collapse signals a pharmacy access crisis
By B. Douglas Hoey, CEO of the National Community Pharmacists Association, which represents more than 18,000 independent pharmacies across the country.
Breaking through congestion in pharmaceutical marketing
By Allison Raplee, media director at Greater Than One, a healthcare media, marketing and technology agency
Relief for the industry can’t come too soon
NACDS and the companies it represents (supermarkets and mass merchants with pharmacies as well as chain drug stores) are tackling those problems head-on, aggressively promoting policy changes that will mitigate the financial challenges facing the industry.
Don’t blame NACDS for chain drug retailing’s decline
David Pinto writes that chain drug retailing in America has been in decline for some considerable time. Many factors must share the blame — but NACDS is not among them.
Pharmacists should be clinical leaders with GLP-1s
By Betty Pio, Laura Bowen, Sarah Scolnic and Christi Rich
Drug chains need to differentiate trends from fads
By Kristin Hornberger, executive vice president and practice leader in wellness and homecare at Circana
Drug chains can be reinvented as beauty destinations
By Jacqueline Flam, senior vice president of beauty, drug and OTC for NielsenIQ